NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
Invented are compounds of formula Iand the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Lim, Yeon-Hee Ding, Fa-Xiang Mak, Victor W Roane, James Patrick Bao, Jianming Hugelshofer, Cedric Lorenz Shockley, Samantha E Yen, Rose Sanzone, Jillian R Cruz, Faben A |
| description | Invented are compounds of formula Iand the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions, comprising administering a compound of Formula I to a patient in need thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024059700A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024059700A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024059700A13</originalsourceid><addsrcrecordid>eNrjZDDx8w9z9VFw8XR0jvRx94l0dg3ydHFV8NcF8UOCHP2C3VyDHINdFYwUPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYmBqaW5gYGjoTFxqgBz5yhr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS</title><source>esp@cenet</source><creator>Lim, Yeon-Hee ; Ding, Fa-Xiang ; Mak, Victor W ; Roane, James Patrick ; Bao, Jianming ; Hugelshofer, Cedric Lorenz ; Shockley, Samantha E ; Yen, Rose ; Sanzone, Jillian R ; Cruz, Faben A</creator><creatorcontrib>Lim, Yeon-Hee ; Ding, Fa-Xiang ; Mak, Victor W ; Roane, James Patrick ; Bao, Jianming ; Hugelshofer, Cedric Lorenz ; Shockley, Samantha E ; Yen, Rose ; Sanzone, Jillian R ; Cruz, Faben A</creatorcontrib><description>Invented are compounds of formula Iand the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions, comprising administering a compound of Formula I to a patient in need thereof.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240222&DB=EPODOC&CC=US&NR=2024059700A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240222&DB=EPODOC&CC=US&NR=2024059700A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lim, Yeon-Hee</creatorcontrib><creatorcontrib>Ding, Fa-Xiang</creatorcontrib><creatorcontrib>Mak, Victor W</creatorcontrib><creatorcontrib>Roane, James Patrick</creatorcontrib><creatorcontrib>Bao, Jianming</creatorcontrib><creatorcontrib>Hugelshofer, Cedric Lorenz</creatorcontrib><creatorcontrib>Shockley, Samantha E</creatorcontrib><creatorcontrib>Yen, Rose</creatorcontrib><creatorcontrib>Sanzone, Jillian R</creatorcontrib><creatorcontrib>Cruz, Faben A</creatorcontrib><title>NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS</title><description>Invented are compounds of formula Iand the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions, comprising administering a compound of Formula I to a patient in need thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDx8w9z9VFw8XR0jvRx94l0dg3ydHFV8NcF8UOCHP2C3VyDHINdFYwUPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkYmBqaW5gYGjoTFxqgBz5yhr</recordid><startdate>20240222</startdate><enddate>20240222</enddate><creator>Lim, Yeon-Hee</creator><creator>Ding, Fa-Xiang</creator><creator>Mak, Victor W</creator><creator>Roane, James Patrick</creator><creator>Bao, Jianming</creator><creator>Hugelshofer, Cedric Lorenz</creator><creator>Shockley, Samantha E</creator><creator>Yen, Rose</creator><creator>Sanzone, Jillian R</creator><creator>Cruz, Faben A</creator><scope>EVB</scope></search><sort><creationdate>20240222</creationdate><title>NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS</title><author>Lim, Yeon-Hee ; Ding, Fa-Xiang ; Mak, Victor W ; Roane, James Patrick ; Bao, Jianming ; Hugelshofer, Cedric Lorenz ; Shockley, Samantha E ; Yen, Rose ; Sanzone, Jillian R ; Cruz, Faben A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024059700A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Lim, Yeon-Hee</creatorcontrib><creatorcontrib>Ding, Fa-Xiang</creatorcontrib><creatorcontrib>Mak, Victor W</creatorcontrib><creatorcontrib>Roane, James Patrick</creatorcontrib><creatorcontrib>Bao, Jianming</creatorcontrib><creatorcontrib>Hugelshofer, Cedric Lorenz</creatorcontrib><creatorcontrib>Shockley, Samantha E</creatorcontrib><creatorcontrib>Yen, Rose</creatorcontrib><creatorcontrib>Sanzone, Jillian R</creatorcontrib><creatorcontrib>Cruz, Faben A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lim, Yeon-Hee</au><au>Ding, Fa-Xiang</au><au>Mak, Victor W</au><au>Roane, James Patrick</au><au>Bao, Jianming</au><au>Hugelshofer, Cedric Lorenz</au><au>Shockley, Samantha E</au><au>Yen, Rose</au><au>Sanzone, Jillian R</au><au>Cruz, Faben A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS</title><date>2024-02-22</date><risdate>2024</risdate><abstract>Invented are compounds of formula Iand the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are DGAT2 inhibitors. Also provided are methods of making compounds of Formula I, pharmaceutical compositions comprising compounds of Formula I, and methods of using these compounds to treat hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions, comprising administering a compound of Formula I to a patient in need thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2024059700A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T01%3A42%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lim,%20Yeon-Hee&rft.date=2024-02-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024059700A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |